Lingling Yang

Chongqing, 400010, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

CC223 enhances cisplatin sensitivity of platinum-resistant ovarian cancer by inducing cell cycle arrest.

CC223 enhances cisplatin sensitivity of platinum-resistant ovarian cancer by inducing cell cycle arrest.

Journal: Journal of ovarian research
Published: August 07, 2025

Bisphenol S drives breast cancer metastasis by inhibiting dopamine receptor D2 to activate the Akt/GSK3β oncogenic axis.

Bisphenol S drives breast cancer metastasis by inhibiting dopamine receptor D2 to activate the Akt/GSK3β oncogenic axis.

Journal: Journal of advanced research
Published: June 10, 2025

From light to insight: Functional near-infrared spectroscopy for unravelling cognitive impairment during task performance.

From light to insight: Functional near-infrared spectroscopy for unravelling cognitive impairment during task performance.

Journal: Bioscience trends
Published: January 26, 2025

FNDC5/Irisin mitigates high glucose-induced neurotoxicity in HT22 cell via ferroptosis.

FNDC5/Irisin mitigates high glucose-induced neurotoxicity in HT22 cell via ferroptosis.

Journal: Bioscience trends
Published: October 16, 2024

The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway.

The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway.

Journal: Cellular signalling
Published: March 04, 2023

Zinc finger and SCAN domain containing 1, ZSCAN1, is a novel stemness-related tumor suppressor and transcriptional repressor in breast cancer targeting TAZ.

Zinc finger and SCAN domain containing 1, ZSCAN1, is a novel stemness-related tumor suppressor and transcriptional repressor in breast cancer targeting TAZ.

Journal: Frontiers in oncology
Published: September 11, 2022

The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery.

The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery.

Journal: Frontiers in oncology
Published: August 26, 2022

Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis.

Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 01, 2022

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.

Journal: Clinical Medicine Insights. Oncology
Published: June 28, 2022

Development of a molecular feature-based survival prediction model of ovarian cancer using the deep neural network.

Development of a molecular feature-based survival prediction model of ovarian cancer using the deep neural network.

Journal: Genes & diseases
Published: June 17, 2022
Showing 1-10 of 10

Last Updated: 09/26/2026